Operating Lease, Right-of-Use Asset in USD of Fresh Tracks Therapeutics, Inc. from Q3 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fresh Tracks Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q3 2019 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2023 was $0, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Fresh Tracks Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $0 -$49,000 -100% 31 Dec 2023 10-K 15 Mar 2024 2023 FY
Q3 2023 $0 -$15,000 -100% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $17,000 -$13,000 -43% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $25,000 -$20,000 -44% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $49,000 -$10,000 -17% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 $15,000 -$57,000 -79% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $30,000 -$56,000 -65% 30 Jun 2022 10-Q/A 01 Sep 2022 2022 Q2
Q1 2022 $45,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $59,000 -$15,000 -20% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $72,000 -$22,000 -23% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $86,000 -$28,000 -25% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q4 2020 $74,000 -$85,000 -53% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $94,000 -$82,000 -47% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $114,000 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $133,000 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $159,000 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $176,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.